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Surface coatings of the albumin-heparin 
conjugates were developed to improve the 
blood compatibility of polymeric materials. 
Glass, PVC, Biomer and cellulose acetate 
were coated with albumin-heparin conju- 
gate and its adsorption and desorption be- 
havior on glass in particular was studied 
using 3H and 51Cr radiolabeled conjugates. 
Precoated materials showed a significant 
prolongation of the Lee-White clotting time 
as compared with noncoated ones. It was 
demonstrated that the prolonged clotting 
time for pretreated glass was due to surface 
bound conjugate. Prolonged recalcifica- 
tion times of plasma exposed to glass, 
Biomer, and PVC were obtained using al- 
bumin-heparin conjugate precoated sur- 
faces. Albumin-heparin conjugates with 
high affinity for antithrombin I11 gave more 
prolonged clotting times as low affinity 
conjugates when used as coatings for 
glass. This indicates that the behaviour of 
heparin in preadsorbed conjugates resem- 
bles that of heparin in solution. 
INTRODUCTION 
In general, a blood compatible material shows low adhesion, aggregation 
and activation of blood platelets and inhibits the surface induced activation 
of the intrinsic coagulation. l t 2  Heparinized polymeric materials, first de- 
scribed by Gott et al.,3 are generally accepted as being relatively thrombo- 
resistant. The preparation and properties of heparinized materials have 
been reviewed by Leini~~ger,~ Ehrl i~h,~ Wilson,6 and Ebert and Kim.7 
The enhanced thromboresistance of materials to which heparin is ionically 
bound is quite well understood. In contact with blood, a controlled release 
of heparin from the material surface takes place providing a high concen- 
tration of heparin at the blood-polymer interface.8 However, the enhanced 
thromboresistance of some materials to which heparin is covalently bound 
is not completely understood. It is not clear whether the enhanced throm- 
boresistance is caused by a “solution-like” behavior of heparin or by a spe- 
cific composition of the protein layer deposited on the heparinized material. 
The first explanation is supported by Larsson et al.9 and by Goosen et 
al.,lo,ll who showed that thrombin was neutralized on with heparin modi- 
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fied polyethylene9 and on polyvinyl alcohol gels due to the action of im- 
mobilized heparin.lOJ Raghunath et al. reported on a covalently bound 
heparin-collagen complex12 and stated that heparin linked to collagen retains 
its antithrombogenic activity. However, they also showed that a substantial 
amount of heparin was released in contact with buffer which can very well 
explain the observed prolonged clotting times. The second explanation is 
supported by Plate and Val~ev, '~ , l~ but no information about the preparation 
of the heparinized materials was provided. Ebert and Kim immobilized 
heparin onto agarose using alkyl spacer groups of various length. It was 
shown that the activity of immobilized heparin was dependent on the length 
of the spacer, whereas the immobilized heparin-platelet interactions were 
independent on the length of the spacer.15 
We recently reported on the synthesis and properties of covalently bound 
conjugates of the plasma protein albumin and the anticoagulant heparin.16 
These compounds were developed as a coating for mainly hydrophobic 
blood contacting biomaterials. The adsorption and desorption of albumin- 
heparin conjugates on hydrophobic and hydrophilic polymers were studied 
and the platelet adhesion from citrated canine blood on biomaterials pread- 
sorbed with albumin-heparin conjugates was investigated using laminar 
flow cells. l7 Compared with uncoated materials, the albumin-heparin con- 
jugate preadsorbed materials showed reduced (up to 70%) platelet adhesion 
numbers. Albumin-heparin conjugates were also immobilized onto CNBr 
activated Sepharose. Plasma previously exposed to these gels showed a 
prolonged clotting time which was not due to release of conjugate but was 
caused by the specific binding of clotting factors IX and XI to the heparin 
part of the conjugate.18 In this study we have investigated the role of hep- 
arin in albumin-heparin conjugates preadsorbed onto different surfaces with 
respect to the inhibition of the surface induced activation of the intrinsic 
coagulation. 
MATERIALS AND METHODS 
Albumin-heparin conjugates 
Albumin-heparin conjugate (further indicated as alb-hep) was obtained 
by coupling albumin (No. A9511, Sigma, St. Louis) and heparin (porcine 
mucosa, 170 U/mg, Diosynth, Oss, The Netherlands) at pH 5.1-5.2 using 
the coupling agent EDC (l-ethyl-3-(3-dimethylaminopropyl)-carbodiimide). 
Alb-hep was separated from unreacted albumin and heparin using DEAE- 
cellulose- and Cibacron Blue Sepharose-chromatography, respectively. Alb- 
hep was fractionated using affinity chromatograph with an antithrombin I1 
(AT 111) Sepharose column yielding high- and low-affinity alb-hep conju- 
gates.16 The anticoagulant activity of the different conjugates was deter- 
mined using an APTT (activated patial thromboplastin time) assay as de- 
scribed previously. l8 51Cr radiolabeled alb-hep was prepared as described 
previ0us1y.l~ 3H radiolabeled alb-hep was obtained as follows. Heparin (45 
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mg) was radiolabeled with 3H using NaB3H, (1.5 mg, 6 mCi, Amersham, 
England) according to the method described by Hatton et a1.19 Subsequently 
albumin and 3H radiolabeled heparin were coupled using ECD, and 3H 
radiolabeled alb-hep was isolated using the chromatographic purification 
procedures described before. 
Adsorption and desorption studies 
The adsorptioddesorption characteristics of alb-hep (51Cr radiolabeled) 
onto/from cellulose acetate, PVC, Biomer and Silastic were published else- 
where.17 The adsorption onto and desorption from glass was studied in 
two independent experiments using both 51Cr and 3H radiolabeled alb-hep. 
A solution of 51Cr radiolabeled alb-hep in PBS (1 mL phosphate buffered 
saline) with the appropriate concentration was pipetted into a glass tube 
(7.7 X 4.6 mm, Payton aggregometer tubes (type 600), Salm and Kipp, 
Breukelen, The Netherlands) at room temperature. The conjugate solution 
contacted a glass surface of 6.2 cm2. After the respective adsorption times, 
the solution of conjugate was removed and the tube was washed five sub- 
sequent times with 1.0 mL aliquots of PBS. The radioactivity on the surface 
was measured with a gamma counter (LKB, type Wallac 1275, Sweden). For 
the determination of the rate of adsorption, bulk concentrations of alb-hep 
of 0.05 and 0.5 mg/ml were used and the adsorption time was varied (30 
min to 5 h). The adsorption isotherm of alb-hep on glass was determined 
by varying the bulk concentration of alb-hep (10-3-10 mg/ml) and applying 
an adsorption time of one hour. For the determination of the desorption of 
alb-hep, glass tubes preadsorbed with 51Cr radiolabeled alb-hep (1 mg/ml, 
one hour) were contacted with human CPD plasma (Bloodbank Twente and 
Achterhoek, Enschede, The Netherlands) at room temperature. After re- 
moval of the plasma solution followed by a single washing cycle of the 
surface with PBS, the remaining surface concentration of alb-hep was mea- 
sured at different time intervals (15 min-5 h). The adsorption of alb-hep 
conjugate onto glass at room temperature was also studied using 3H labeled 
conjugate. A solution of 3H labeled alb-hep in PBS (1 mL) was pipetted into 
a polystyrene tube (11.5 x 55 mm). Then a glass tube (same specifications 
as used for the experiments with 51Cr labeled conjugate) was brought into 
this polystyrene tube. Care was taken that the alb-hep solution contacted 
only the outside of the glass tube (contact area 7.7 cm2). After the required 
adsorption time, the glass tube was removed from the alb-hep solution and 
the outside of the tube was extensively washed with PBS in order to remove 
nonadsorbed conjugate. The radioactivity on the surface was measured in 
the presence of the counting liquid (4 ml) plasmasol (Packard Becker, 
Brussel, Belgium) using a Packard Tricarb Model 3255 liquid scintillation 
counter. The observed cpm for all samples were converted into dpm using 
the SCR (sample channels ratio) and a calibration curve obtained by counting 
a known amount of 3H in the presence of varying concentrations of acetone. 
The adsorption of alb-hep on glass was determined by varying the bulk 
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concentration of conjugate (10-3-1 mg/mL) and applying an adsorption time 
of one hour. 
Lee-White clotting times 
Glass tubes (Borosilicate (13 X 100 mm), Fischer Scientific Company, Pitts- 
burg, Pa.) were coated with Biomer (Ethicon Co., Somersville, N.J.), poly- 
vinyl chloride (PVC, Bentley Laboratories, Irvine, Ca.), or cellulose acetate 
(CA, acetyl content 39.8%, Aldrich Chemical Co., Milwaukee, Wis.) ac- 
cording to the following procedures. Glass tubes were filled with a 10% 
solution of Biomer or PVC in dimethyl acetamide. After emptying the tubes, 
they were set upright and placed in an oven at 60°C. After 10 min and 1 
h, respectively, any remaining solution was removed from the bottom using 
a pasteur pipette. After 6 h, the tubes were vacuum dried overnight at the 
same temperature. Glass tubes were coated with CA using a 5% solution 
in acetone. The solvent was removed by slow evaporation for 6 h at room 
temperature in an acetone atmosphere. 
The uncoated glass tubes and the PVC-, CA- and BiomerB-coated tubes 
were then coated with a solution of alb-hepm (5 mg/ml) in 0.9% NaCl, 25 
mM Tris/HCl, ph 7.4 (buffer A). After an adsorption time of 1 h, the tubes 
were thoroughly washed with buffer A in order to remove nonadsorbed 
alb-hep. After the last washing cycle, 1 mL of blood was added to both the 
uncoated glass, the PVC-, CA-, and Biomer-coated tubes (controls) and the 
tubes coated with alb-hep. The control tubes were incubated with buffer A 
for one hour before the addition of the blood. Using a double syringe 
technique, blood samples were drawn from anesthetized dogs via Angiochat 
Teflon catheter (The Deseret Co., Sandy, U.S.A.) which was inserted into 
the jugular vein. Lee-White clotting times were determined as described by 
Coleman et 
The effect of preadsorbed albumin or different alb-hep conjugates on the 
Lee-White clotting times was investigated using glass as a substrate. Glass 
tubes were preadsorbed for 1 h with solutions (5 mg/mL in buffer A) of 
either albumin, alb-hep, high affinity alb-hep or low affinity alb-hep. After 
washing the tubes with buffer A, Lee-White clotting times were determined. 
In addition, the relationship between the alb-hep blood concentration and 
the Lee-White clotting time was established by measuring clotting times of 
1 mL amounts of blood which were added to glass tubes (uncoated) con- 
taining different amounts of alb-hep in buffer A (2,4,6,8, pL of a solution 
of 1 mg/mL). All Lee-White determinations were carried out at 37°C. 
Plasma recalcification times 
The recalcification times of plasma in contact with uncoated and with alb- 
hep coated glass, PVC and Biomer were determined. The clotting time of 
plasma after the addition of calcium chloride was measured by continuously 
following the turbidity of plasma using a two-channel Payton aggregometer 
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Figure 1. Change in transmission (%) as a function of time of recalcified 
citrated plasma exposed to uncoated glass (-) and to glass previously 
coated with albumin-heparin conjugate (10 p/mL, 1 h) (---). Arrows indicate: 
I, incubation for 2 min at 37°C of citrated plasma in a glass tube; 11, addition 
of CaCl,; 111, stage where the first fibrin polymers are formed and taken as 
“the recalcification time.” 
(Salm and Kipp, Breukelen, The Netherlands). All measurements were car- 
ried out with glass tubes (7.7 x 46 mm, Payton aggregometer tubes (type 
600), Salm and Kipp, Breukelen, The Netherlands) and with glass tubes 
coated with PVC and Biomer. The same coating procedure for glass with 
PVC and Biomer was followed as described under the ”Lee-White clotting 
times” section. Plasma recalcification times were measured according to the 
following procedure. Human CPD plasma (350 kl, Bloodbank Twente and 
Achterhoek, Enschede, The Netherlands) was pipetted into a tube. This 
tube was placed into the aggregometer thermostated at 37°C. After an in- 
cubation time of exactly 2 min, CaC1, (50 pL, 100 mM in buffer A) was 
added and the turbidity of the plasma solution was measured against a 
reference. This reference was a fully coagulated sample of plasma obtained 
by mixing plasma (350 pL) and CaCl, (50 wL, 100 mM in buffer A) followed 
by an incubation period of 30 min. Examples are given for glass and glass 
pretreated with alb-hep (Fig. 1). The time where the transmission is de- 
creasing (arrow I11 in Fig. 1) is taken as the plasma recalcification time. 
PVC and Biomer were coated with a solution of alb-hep (0.1 mglmL in 
buffer A) for 1 h. After removing the nonadsorbed conjugate by washing 
the tubes thoroughly with buffer A, plasma was added and the recalcifica- 
tion time was determined as described above. Control experiments were 
carried out by measuring recalcification times of plasma in contact with 
nontreated and with albumin coated (0.1 mg/mL in buffer A for one hour) 
PVC and Biomer. The effect on the recalcification time of plasma in contact 
with glass previously pretreated with varying concegtrations of respectively 
albumin, alb-hep, high affinity alb-hep and low affinity alb-hep in buffer A 
was also studied. Adsorption times of one hour were applied and the tubes 
were washed thoroughly with buffer A before the addition of the plasma. 
In order to establish the relationship between the alb-hep concentration 
in plasma and the plasma recalcification time, small volumes of alb-hep (0.5- 
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Figure 2. The adsorption of alb-hep conjugate onto glass as a function of 
time. (0) 0.05 mg/mL; (0) 0.5 mg/mL. Measurements were carried out using 
51Cr radiolabeled albumin-heparin conjugate. 
8 p.L of a 1 mg/mL solution in buffer A) were mixed with 350 pL of plasma 
and the recalcification times were measured as described below. These mea- 
surements were carried out for plasma in contact with glass, PVC or Biomer. 
To determine the effect of desorbed conjugate on the plasma recalcifica- 
tion times, an additional experiment was carried out. Twelve glass tubes 
were incubated with a 10 pg/mL solution of alb-hep. After an incubation 
time of 2 min at 37"C, recalcification times of plasma of six tubes were 
measured. After 15 min of incubation at 37"C, the plasma of the other 6 
tubes was transferred to 6 uncoated glass tubes and recalcification times 
were measured. 
Special attention was given in handling the plasma for the recalcification 
experiments. The plasma was received deep frozen -70°C in 200 mL 
batches. It was thawed quickly at 37"C, divided into 10 mL portions and 
stored at - 30°C in polypropylene vials. Before each experiment the plasma 
was thawed at 37°C and stored in an ice bath. Plasma was not used for a 
longer period than 3 h after being thawed. 
RESULTS 
Adsorption-desorption behavior of alb-hep at glass surfaces 
Figures 2, 3, and 4 show the adsorption and desorption characteristics of 
alb-hep on glass using both 3H and 51Cr labeled conjugate. From Figure 2 
it appears that the plateau value for adsorption is reached within 1 h. Figure 
3 shows the adsorption isotherm of alb-hep on glass. Within the range 
where experiments were carried out using 3H and 51Cr labeled alb-hep 
(0.001-1 mg/mL), results obtained with both labels are in good agreement. 
Due to the elaborate synthetic procedures involved, the adsorption with 3H 
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and 3H (0) radiolabeled conjugate. 
Adsorption of albumin-heparin conjugate on glass using 51Cr (A) 
labeled conjugate was only studied at bulk concentrations up to 1 mg/ml. 
Figure 4 shows the desorption of alb-hep from glass in the presence of 
plasma. During the first 30-60 min of contact with plasma, 50-60% of the 
adsorbed conjugate is exchanged by plasma proteins and thereafter no fur- 
ther desorption is observed. 
Lee-White clotting times 
Lee-White clotting times of whole blood in contact with glass, CA, Biomer, 
and PVC with and without an alb-hep coating were determined. As a ref- 
erence, the clotting time of blood in contact with glass was measured for 
each experiment. This value varied from 8-12 min. The observed clotting 
times for blood in contact with the different materials were divided by the 
P W M A  CONTACT TIME LHrI 
Figure 4. 
ence of citrated plasma as a function of time. 
Desorption of albumin-heparin conjugate from glass in the pres- 
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Figure 5. Ratios of Lee-White clotting times of blood exposed to different 
materials both uncoated (0) and coated with albumin-heparin conjugate (5 
mg/ml) (0) All plotted values are the means ( 5  S.D.) of eight experiments. 
value observed for glass yielding clotting time ratios given in Figure 5. Av- 
erage ratios were obtained by repeating the experiments several times (N = 
8) using five different dogs. From Figure 5 it appears that the Lee-White 
clotting time is prolonged when the different materials were preadsorbed 
with alb-hep. This prolongation is dependent on the type of material tested 
and varied from 30% (CA) to 100% (PVC). 
Figure 6 shows the Lee-White clotting times of blood in contact with glass 
which was previously treated with albumin or with different alb-hep con- 
jugates. From this figure it appears that, compared with uncoated glass, 
an albumin coating hardly affected the Lee-White clotting time. On the 
other hand glass preadsorbed with different alb-hep conjugates show strong 
T 
Figure 6. Ratios of Lee-White clotting times of blood exposed to glass coated 
with albumin (D), glass coated with low-affinity albumin-heparin conjugate 
(a), glass coated with nonfractionated albumin-heparin conjugate (El), glass 
coated with high-affinity albumin-heparin conjugate (a), and uncoated glass 
(a). All plotted points are the means (+- S.D.) of five experiments. 
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TABLE I 
Statistical Significance of Differences in Lee-White Clotting Times of Blood Exposed to 
Glass Pretreated with Albumin and Different Albumin-Heparin Conjugates as shown in 
Figure 6 using Student’s t-test 
Nonfractionated Low-affinity 
alb-hep a 1 b - h e p Uncoated 
Type of coating conjugate conjugate Albumin glass 
High-affinity alb-hep 0.01 < p < 0.02 0.01 < p < 0.02 ~ 0 . 0 1  <0.01 
Nonfractionated 0.05 < p < 0.1 CO.01 <0.01 
Low-affinity alb-hep <0.01 <0.01 
alb-hep 
Albumin 0.1 < p < 0.2 
differences. The strongest prolongation is observed for glass preadsorbed 
with high affinity alb-hep, whereas for low affinity alb-hep only a slight 
prolongation is observed. Table I gives a statistical analysis of the results 
of Figure 6. From this table it appears that, except for the combinations 
nonfractionated alb-hep conjugate-low-affinity conjugate and albumin-un- 
coated, all mean values differ significantly ( p  < 0.05, Student’s t-test). 
Figure 7 gives the relationship between the concentration of alb-hep in 
blood and the Lee-White clotting times of these blood samples exposed to 
uncoated glass. 
Plasma recalcification times 
A typical plot of the turbidity (% transmission) of plasma in contact with 
glass (untreated and treated with alb-hep) is shown in Figure 1. After the 
addition of CaCl, (t = 0) no decrease in % transmission is observed during 
3 min for uncoated glass and during 7 min for glass previously treated with 
alb-hep (10 pg/mL in buffer A). After that the transmission is decreasing 
which is caused by polymerization and cross-linking of formed fibrin mono- 
mers. 
The results of plasma recalcification time studies are presented in the 
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Figure 7. Ratios of Lee-White clotting times of blood in the presence of 
different concentrations of albumin-heparin conjugate and blood in the ab- 
sence of albumin-heparin conjugate. All plotted points are the means 
(?  S.D.) of five experiments. 
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bumin coated (a) and with albumin-heparin coated (69) Biomer and PVC. 
Recalcification times of plasma exposed to uncoated (0) with al- 
Figures 8 through 12. Figure 8 shows that the recalcification times of plasma 
exposed to Biomer and PVC precoated with alb-hep conjugate are strongly 
prolonged (170 and 220% as compared with uncoated Biomer and PVC, 
respectively), whereas as a precoating with albumin gives only a slight pro- 
longation (15 and 14%). When glass is contacted with solutions containing 
varying concentrations of alb-hep, a curve as shown in Figure 9 is observed. 
A prolongation of the plasma recalcification time of almost 400% is obtained 
when glass was precoated with a 0.03 mg/mL solution of alb-hep. When 
higher concentrations for the coating were used (up to 10 mg/mL), no further 
prolongation was observed. It was found that the concentration of the alb- 
hep solution used for coating of the glass tubes which induced a plateau 
value in the plasma recalcification time as well as the slope of the linear part 
of the plot, were both dependent on the batch of plasma used. Figure 10 
shows the plasma recalcification time as a function of the albumin concen- 
tration used for coating of the glass tubes. It appears that in the concentra- 
tion range (0-0.03 mg/mL) where alb-hep conjugate affects the clotting to a 
high extent, an albumin coating does not cause a significant prolongation 
of the plasma recalcification time. As expected, heparin does not absorb 
onto glass. Glass tubes were contacted with a solution of heparin (1 mg/ 
mL) for 1 h. After washing, plasma was added and the recalcification time 
was measured. The observed average recalcification time was the same as 
for plasma exposed to uncoated glass. Figure 11 shows the recalcification 
times of plasma in contact with glass which was previously treated with 
different alb-hep conjugates. From this figure it can be observed that a 
coating of high affinity alb-hep conjugate is 2-4 times more effective in 
preventing surface induced coagulation than a corresponding coating of 
nonfractionated conjugate, whereas a coating of low-affinity conjugate does 
not have any effect on the plasma recalcification time in the concentration 
range shown. 
Relationships between plasma alb-hep concentration and recalcification 
times of this plasma exposed to glass, Biomer and PVC were established. 
Figure 12 gives the results. 
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Figure 9. Recalcification times of plasma exposed to glass previously treated 
with buffer solutions containing different concentrations of albumin-heparin 
conjugate. 
Table I1 shows the results of the recalcification times of plasma exposed 
to glass pretreated with alb-hep, the recalcification times of plasma exposed 
to the same tubes and transferred to uncoated tubes after an incubation time 
of 15 min and the recalcification time of plasma exposed to uncoated glass. 
DISCUSSION 
The adsorption and desorption characteristics of alb-hep conjugate on 
glass are to some extent comparable with data measured for the adsorption 
onto and desorption from the hydrophobic polymers Biomer, PVC, and 
Sila~tic.'~ Plateau values are reached within one hour for the adsorption of 
alb-hep onto both glass and the polymers mentioned above. In contact with 
plasma, exchange of adsorbed alb-hep with plasma proteins is observed for 
both glass and the hydrophobic polymers and there is also agreement with 
respect to the amount of adsorbed conjugate which is released into the 
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Figure 10. Recalcification times of plasma exposed to glass previously 
treated with buffer solutions containing different concentrations of albumin. 
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Figure 11. Recalcification times of plasma exposed to glass previously 
treated with buffer solutions containing different concentrations of nonfrac- 
tionated albumin-heparin conjugate (A), low-affinity albumin-heparin con- 
jugate (O), and high-affinity albumin-heparin conjugate (0). 
plasma. For glass, Biomer, PVC, and Silastic within the first 1-2 h of contact 
between the materials preadsorbed with alb-hep and plasma, approximately 
50% of the adsorbed amount of conjugate is exchanged and after that no 
further release is observed. Similar desorption curves have been published 
by Baszkin and Lyman for prealbuminated polymers in contact with 
plasma.21 The adsorption isotherm of alb-hep on glass (Fig. 3) deviates from 
the ones published for Biomer, PVC, and Sila~tic.'~ For the latter polymers, 
surface concentrations of 0.5-0.6 pg/cm2 at a bulk concentration of 10 mg/ 
ml were observed, whereas for glass, at the same bulk concentration a value 
of 1.5 pg/cm2 was measured. The results obtained with 3H labeled alb-hep 
and 51Cr labeled are in agreement with each other which suggests that (on 
glass) no preferential adsorption of labeled conjugate occurs. 
The results obtained with the Lee-White tests demonstrate that, compared 
0 2 4 6 8  
ALE-HEP CONJUGATE ( ~ 4 )  IN PLASMA 
Figure 12. Recalcification times of plasma (350 yL) containing different 
amounts of albumin-heparin conjugate, exposed to glass (0), Biomer (A), 
and PVC (0). 
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TABLE I1 
Recalcification Times of Plasmas (in minutes 2 S.D., N = 6 
Exposed to glass 
pretreated with with alb-hep and transferred Exposed to uncoated 
alb-hep to uncoated glass tubes glass tubes 
Exposed to glass pretreated 
6.6 * 1.0 2.8 ? 0.2 3.0 * 0.3 
with uncoated materials, the clotting times of whole blood exposed to ma- 
terials (glass, Biomer, PVC, CA) previously treated with alb-hep are signif- 
icantly prolonged. Using the data presented in Figures 3 and 4, it can be 
calculated that the maximum amount of conjugate released into the blood 
(1 mL) within 20 min of contact (maximum clotting time observed for glass 
preadsorbed with alb-hep) is 1 pg, assuming that the desorption behaviour 
of alb-hep in the presence of whole blood is the same as in the presence of 
citrated plasma. From Figure 7 it appears that this amount of released alb- 
hep causes only a slight prolongation (10-20%) of the Lee-White clotting 
time. So it can be concluded that the observed prolongation of the Lee- 
White clotting time can not be described to the release of adsorbed alb-hep 
into the blood phase. Figure 6 shows that preadsorption of glass with al- 
bumin gives a minor prolongation of Lee-White clotting times. Therefore 
we expect that albumin in alb-hep also will not contribute to the observed 
prolongation in Lee-White clotting times. 
This means that the effects are due to surface adsorbed alb-hep conjugate. 
The observed clotting time of whole blood exposed to a material is the result 
of both activation of the intrinsic coagulation as well as platelet adsorption 
and activation on this material surface. Therefore, using only the results of 
the Lee-White tests, it is difficult to evaluate the mechanism of the surface 
bound alb-hep induced inhibition of the coagulation. Figure 6 shows that 
surface bound high affinity alb-hep is a better inhibitor of the surface in- 
duced coagulation than low-affinity alb-hep. From this we conclude, as- 
suming that the rate of activation of the intrinsic coagulation is the same on 
both surfaces, that the heparin part of the surface bound alb-hep neutralizes 
activated clotting factors formed at the material-blood interface. Since we 
observed that the initial platelet adhesion onto materials preadsorbed with 
alb-hep was strongly reduced and that a material preadsorbed with different 
conjugates (low- and high-affinity) showed different platelet adhesion num- 
b e r ~ , ~ ~  it can not be excluded that the prolonged Lee-White clotting times 
are also due to reduced platelet adhesion and activation on the material 
surface. 
The results obtained from the recalcification time studies clearly show that 
the recalcification times of plasma in contact with Biomer, PVC, and glass 
preadsorbed with alb-hep were strongly prolonged. Using the adsorption 
and desorption data of alb-hep available for glass (Figure 3 and 4) and for 
Biomer and PVCI7 and a contact area between the surface and the plasma 
of 2.5 cm2, it can be calculated that the maximum amounts of alb-hep which 
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are released into the plasma during the recalcification measurements are 
0.06, 0.03, and 0.04 pg for glass, Biomer, and PVC, respectively. From this 
it can be concluded, using the data of Figure 12, that the observed prolon- 
gations of the recalcification times of plasma exposed to glass, Biomer, and 
PVC previously coated with alb-hep cannot be ascribed to release of con- 
jugate from the surface. This conclusion is confirmed by the results pre- 
sented in Table 11. Since the observed prolonged plasma recalcification 
times can not be ascribed to the release of conjugate into the plasma nor to 
the albumin part of adsorbed conjugate (Figure lo), we conclude that surface 
bound alb-hep is a very effective inhibitor of the surface induced activation 
of the intrinsic coagulation. Using different conjugates (nonfractionated, 
high- and low-affinity, Figure 11) more information is obtained about the 
mechanism of surface bound alb-hep conjugate inhibition of the activation 
of the intrinsic coagulation. Preadsorption of glass with low affinity con- 
jugate does not influence the recalcification time of plasma, whereas pread- 
sorption with high affinity conjugate strongly prolonged the plasma recal- 
cification time. Surface bound nonfractionated alb-hep has an activity which 
is 30-50% of the activity of high affinity conjugate. These results show a 
strong resemblance with literature data available for the solution behaviour 
of heparin fractionated with immobilized AT III.22,23 Therefore we conclude 
that the mechanism of action of surface bound alb-hep is the same as pro- 
posed for bulk heparin.24 The observation that after exposure to plasma a 
substantial amount of AT I11 was detected on polystyrene treated with alb- 
supports the proposed mechanism. This mechanism is different from 
that proposed by Goosen et al.,lo,ll who stated that AT I11 reacts after that 
thrombin is bound to covalently bound heparin. However, Goosen et al. 
only consider the inactivation of thrombin and they do not pay attention to 
the fact that heparin and AT I11 were also able to neutralize the activity of 
other activated clotting factors (Xa, IXa, XIa and XIIa).26-29 In addition, 
thrombin is very active in the blood coagulation (e.g., stimulation of platelet 
aggregation, stimulation of its own formation) and therefore it is likely that 
when (traces of) thrombin are formed, thrombus formation can hardly be 
avoided. This means that a heparinized material, when effective in the 
inhibition of fibrin formation, probably inhibits the generation of thrombin 
rather than thrombin activity, which was demonstrated with soluble hep- 
arin.30 
In conclusion, surface bound alb-hep is very effective in inhibiting the 
surface induced coagulation, as measured with Lee-White clotting times and 
plasma recalcification times. It was demonstrated that release of adsorbed 
conjugate from the surface into the plasma (blood) does not cause the ob- 
served prolongation of clotting times. It was shown that AT I11 interacting 
with alb-hep conjugate is involved in the inhibition of the intrinsic coagu- 
lation at the plasma material interface. From this, we conclude that the 
mechanism of action of heparin present in the surface bound alb-hep con- 
jugate is similar to that of bulk heparin. 
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